Ilika PLC CEO Graeme Purdy talked with Proactive's Stephen Gunnion about the company’s progress in the first half of its 2025 financial year, highlighting developments in both the Stereax and Goliath battery lines.
Purdy shared that the commercial production of Stereax is well underway, with the first revenues expected this year. He detailed how a licensing agreement with Cirtec Medical has streamlined the transfer of equipment and enabled the initiation of production batches, with customer integration set to follow.
Regarding Goliath, Purdy explained the successful testing of P1 prototypes and the significant progress in safety performance. The company’s D6 milestone resulted in a 10Ah battery, which is five times larger than the previous prototypes. This summer, Ilika aims to release its next round of prototypes and is on track to develop its P2 minimum viable product by year-end, which could spark manufacturing and licensing opportunities.
Despite extensive development, Ilika ended the period with a cash position of over £10 million, surpassing market expectations. Purdy emphasised the company’s efficiency, noting it has achieved significant progress with limited resources.
Stay tuned for updates on Stereax commercialization and Goliath's next prototypes.
Visit Proactive's YouTube channel for more updates like this, and don’t forget to like, subscribe, and enable notifications for future videos.
#Ilika #BatteryTechnology #Stereax #Goliath #SolidStateBatteries #CleanEnergy #EnergyStorage #CirtecMedical #TechInnovation #ElectricVehicles #BatterySafety #Sustainability
